Author:
Ali Shah Syed Hasnain,Ali Wajid,Ali Shah Furqan,Fahad Falah Shaikh,Rehman Erum,Umar Amna,Hidayat Yumna,Afreen Saira,Riaz Aayesha,Ullah Irfan
Abstract
Antibiotic usage and misuse increases the risk of developing bacteria that are resistant to treatment. A Gram-negative, aerobic bacillus called Pseudomonas aeruginosa is mostly responsible for nosocomial opportunistic infections. Objectives: To assess pathogen load and drug susceptibility profiles of Peshawar clinical specimens collected with MDR Pseudomonas aeruginosa isolates. Methods: Isolates were gathered from a variety of specimens, including pus, tracheal aspirate, swabs containing wound samples, fluids such as urine or blood, from department of microbiology hospital of Khyber teaching Peshawar. Clinical in-vitro study which were carried out at the Pharmacology Department, University of Peshawar. Kirby Bauer Disc diffusion method was used to identify the pattern of antibiotic susceptibility. Requirements of Clinical and Laboratory Standards Institute (2018) were followed for processing samples. Results: P. aeruginosa was found to be multidrug-resistant in about 56 percent of cases. The majority of the isolates (36.5%) were found in people between the ages of "60-80". Pus included the greatest percentage of MDR P. aeruginosa (34.2%), followed by tracheal aspiration (21.7 percent). Colistin had the highest sensitivity (100%) and was followed by ceftolozane/tazobactam (61 percent). With imipenem, the least sensitivity was noticed (20 percent). However, all anti-pseudomonal medications showed an increase in resistance. Conclusion: In our system, MDR P. aeruginosa infections are becoming more frequent. This threat can be avoided by prescribing antibiotics carefully. For the community to receive appropriate healthcare, regular lab identification and surveillance of this resistant pathogen is necessary
Publisher
CrossLinks International Publishers
Reference20 articles.
1. 1. Shrivastava G, Bhatambare GS, Patel KB. Evaluation of prevalence and antibiogram of multi drug resistant, extensively drug resistant and pan drug resistant Pseudomonas aeruginosa in patients visiting a tertiary care hospital in central India. CHRISMED Journal of Health and Research. 2014 Jul; 1(3):145. doi: 10.4103/2348-3334.138882
2. 2. Ullah W, Qasim M, Rahman H, Bari F, Khan S, Rehman ZU, et al. Multi drug resistant Pseudomonas aeruginosa: Pathogen burden and associated antibiogram in a tertiary care hospital of Pakistan. Microbial Pathogenesis. 2016 Aug; 97:209-12. doi: 10.1016/j.micpath.2016.06.017
3. 3. Gill MM, Usman J, Kaleem F, Hassan A, Khalid A, Anjum R, et al. Frequency and antibiogram of multi-drug resistant Pseudomonas aeruginosa. Journal College of Physicians and Surgeons Pakistan. 2011 Sep; 21(9):531-4
4. 4. Ali Z, Mumtaz N, Naz SA, Jabeen N, Shafique M. Multi-drug resistant pseudomonas aeruginosa: a threat of nosocomial infections in tertiary care hospitals. Journal of Pakistan Medical Association. 2015 Jan; 65(1):12-6.
5. 5. Islam KA, Khan MA, Azhar S, Ahmed MR, Khurram S, Masood H, et al. Comparison Of In Vitro Activity of Colistin with Ceftolozane/Tazobactam against Multi Drug Resistant Pseudomonas Aeruginosa "A Last Line Treatment against Mdr". American International Journal of Multidisciplinary Scientific Research. 2020 Oct ; 6(3):1-7. doi: 10.46281/aijmsr.v6i3.823